By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Alibaba Health Information Technology Limited

Alibaba Health Information Technology Limited (0241.HK)

HKSE Market Data in HKD, Fundamentals in CNY
$5.83
+$0.37
+6.78%
Last Update: 1 Sept 2025, 03:36
$93.90B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$2.66 - $6.70
52 Week Range

0241.HK Stock Price Chart

Explore Alibaba Health Information Technology Limited interactive price chart. Choose custom timeframes to analyze 0241.HK price movements and trends.

0241.HK Company Profile

Discover essential business fundamentals and corporate details for Alibaba Health Information Technology Limited (0241.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

6 Jul 1972

Employees

1.42K

CEO

Difan Shen

Description

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark. In addition, it engages in the tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong.

0241.HK Financial Timeline

Browse a chronological timeline of Alibaba Health Information Technology Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 18 May 2026

Upcoming earnings on 13 Nov 2025

Earnings released on 18 May 2025

EPS came in at $0.06 falling short of the estimated $0.08 by -14.28%, while revenue for the quarter reached $17.42B , beating expectations by +2.39%.

Earnings released on 13 Nov 2024

EPS came in at $0.07 surpassing the estimated $0.07 by +1.22%, while revenue for the quarter reached $15.79B , missing expectations by -4.54%.

Earnings released on 28 May 2024

EPS came in at $0.06 surpassing the estimated $0.05 by +19.99%, while revenue for the quarter reached $15.22B , beating expectations by +13.35%.

Earnings released on 26 Mar 2024

EPS came in at $0.04 surpassing the estimated $0.01 by +228.89%, while revenue for the quarter reached $13.90B , beating expectations by +0.57%.

Earnings released on 24 May 2023

EPS came in at $0.03 falling short of the estimated $0.03 by -8.34%, while revenue for the quarter reached $17.42B , missing expectations by -49.58%.

Earnings released on 29 Nov 2022

EPS came in at $0.01 , while revenue for the quarter reached $12.63B , missing expectations by -1.16%.

Earnings released on 31 Mar 2022

EPS came in at -$0.00 surpassing the estimated -$0.02 by +83.32%, while revenue for the quarter reached $13.83B , beating expectations by +19.31%.

Earnings released on 30 Sept 2021

EPS came in at -$0.02 , while revenue for the quarter reached $11.29B , missing expectations by -1.16%.

Earnings released on 31 Mar 2021

EPS came in at $0.01 , while revenue for the quarter reached $9.90B , missing expectations by -12.51%.

Earnings released on 30 Sept 2020

EPS came in at $0.02 , while revenue for the quarter reached $8.17B .

0241.HK Stock Performance

Access detailed 0241.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run